ArtProtein partners with you to deliver high‑yield cell lines, robust processes, and IND‑ready data. CHO/HEK platforms. Non‑GMP scale‑up. U.S.–based team.
CHO/HEK stable cell lines with multi‑g/L productivity. Monoclonality and stability confirmed.
DoE‑driven upstream and downstream optimization with clear CPP/CQA mapping.
Identity, purity, glycan/charge, potency, and safety methods developed for tech transfer.
Engineering runs and tox supply to de‑risk GMP; complete documentation for IND/CMC.